DMBA (7,anthracene), a member of the polyaromatic hydrocarbons (PAHs), is an immune-suppressor and potent organ-specific pro-carcinogen and pre-mutagenic. 1 Recent data submits that DMBA provokes the generation of free radicals such as intracellular hydroxyl and superoxide anion radicals and other reactive oxygen species (ROS) that potentiate lipid peroxidation, DNA damage, and exhaustion of the cellular antioxidant capacities, as well as disruption of a variety of biochemical pathways. 1,2 The kidneys are particularly vulnerable to DMBA-induced toxicities. They are metabolically active and receive a quarter of cardiac output (despite weighing below 1% of total body weight). They also filter water out from the filtrate and may thus concentrate and accumulate these toxic substances. 3,4 DMBA exposure has been shown to induce marked histological alternations in kidney, e.g., dilation of tubules and sloughing of the epithelium (signifying enhanced disintegration of tubules); with the epithelial cells of proximal convoluted tubules and Bowman's capsule being especially sensitive to DMBA-induced toxicity. 5,6